119 related articles for article (PubMed ID: 2476650)
1. Inhibition of herpes simplex virus type 1 (HSV-1) plaque enlargement by neutralizing sera.
Mannini-Palenzona A; Costanzo F; Foà-Tomasi L; Negosanti M; Lanzoni A
Microbiologica; 1989 Jul; 12(3):231-40. PubMed ID: 2476650
[TBL] [Abstract][Full Text] [Related]
2. Passive immune protection by herpes simplex virus-specific monoclonal antibodies with different plaque development inhibition activity.
Mannini-Palenzona A; Costanzo F; Cassai E; Campana G
New Microbiol; 1993 Jul; 16(3):205-13. PubMed ID: 8396193
[TBL] [Abstract][Full Text] [Related]
3. [Investigations concerning the evidence of herpes simplex virus type 2 (HSV-2) antibodies in patients with carcinoma of the cervix (author's transl)].
Dostal V; Fanta D; Reiss-Gutfreund RJ; Janisch H; Berger R
Wien Klin Wochenschr; 1977 Mar; 89(6):201-3. PubMed ID: 191994
[TBL] [Abstract][Full Text] [Related]
4. The elimination of herpes simplex plaques by antibody and the emergence of resistant strains.
Pavan PR; Ennis FA
J Immunol; 1977 Jun; 118(6):2167-75. PubMed ID: 193992
[TBL] [Abstract][Full Text] [Related]
5. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
Kohl S; Loo LS
J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
[TBL] [Abstract][Full Text] [Related]
6. Reactions of immune sera against the nucleocapsid, envelope and whole herpes simplex virus type 1.
Lesso J; Hána L; Matis J
Acta Virol; 1976 Feb; 20(1):48-52. PubMed ID: 7940
[TBL] [Abstract][Full Text] [Related]
7. Antibodies against herpes simplex virus in a group of healthy humans without reactions to herpes simplex virus antigens in blasttransformation assays.
Møller-Larsen A
J Clin Lab Immunol; 1986 Jul; 20(3):121-7. PubMed ID: 3018253
[TBL] [Abstract][Full Text] [Related]
8. [Herpes simplex virus].
Chylak J; Cybulski Z; Pietkiewicz K
Pol Tyg Lek; 1979 Jan; 34(2):65-8. PubMed ID: 218179
[No Abstract] [Full Text] [Related]
9. Enzyme immunoassay for detection of antibodies against herpes simplex virus with the use of different viral antigens.
Maltseva NN; Zvonarev AYu ; Matsevich GR; Ebralidze LK
Acta Virol; 1987 May; 31(3):226-33. PubMed ID: 2888286
[TBL] [Abstract][Full Text] [Related]
10. Some immunological characteristics of subjects suffering from frequent herpes simplex virus recrudescences.
Doutlík S; Kutinová L; Benda R; Kamínková J; Krcmár M; Votruba T; Suchánková A; Vonka V; Vacek Z
Acta Virol; 1989 Sep; 33(5):435-46. PubMed ID: 2576584
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus microneutralization: a simplification of the test.
Stalder H; Oxman MN; Herrmann KL
J Infect Dis; 1975 Apr; 131(4):423-30. PubMed ID: 163870
[TBL] [Abstract][Full Text] [Related]
12. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
Morrison LA; Knipe DM
Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
[TBL] [Abstract][Full Text] [Related]
13. A review of the identification and titration of antibodies to herpes simplex viruses type 1 and type 2 in human sera.
Plummer G
Cancer Res; 1973 Jun; 33(6):1469-76. PubMed ID: 4352384
[No Abstract] [Full Text] [Related]
14. [Monoclonal antibodies which recognize herpes simplex virus and their possible diagnostic application].
Pupo Antúnez M; Hermida Díaz C; Morier Díaz L; García Infante S; Resik Aguirre S
Rev Cubana Med Trop; 1997; 49(3):181-5. PubMed ID: 9685985
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of antibodies to type 2 herpes simplex virus in the sera of town population.
Strézová V; Kopecký K; Svandová E; Fadrhoncová A; Teplý V
J Hyg Epidemiol Microbiol Immunol; 1975; 19(3):375-82. PubMed ID: 171307
[TBL] [Abstract][Full Text] [Related]
16. Studies on the neutralizing antibody to herpes simplex virus. III. Detection of type-specific antibody by slow-reacting complement-requiring neutralizing antibody assay.
Ohashi M; Ozaki Y
Microbiol Immunol; 1982; 26(7):569-74. PubMed ID: 7132789
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1.
Vollstedt S; Franchini M; Alber G; Ackermann M; Suter M
J Virol; 2001 Oct; 75(20):9596-600. PubMed ID: 11559791
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus type-specific antibodies detected by indirect and competition ELISA. Comparison of sera from patients with carcinoma of the uterine cervix, age matched controls and patients with recurrent genital herpes.
Najem SN; Vestergaard BF; Potter CW
Acta Pathol Microbiol Immunol Scand B; 1983 Jun; 91(3):205-7. PubMed ID: 6308950
[TBL] [Abstract][Full Text] [Related]
19. [Comparative value of temperature marker and neutralization test for subtyping of herpes simplex viruses (author's transl)].
Langlois M; Gibert R; Aymard M; Denis J
Ann Microbiol (Paris); 1979; 130B(2):245-61. PubMed ID: 231398
[TBL] [Abstract][Full Text] [Related]
20. Salivary neutralizing activity against herpes simplex virus type 1.
Gyselink R; Coles D; Ash RJ; Fritz ME
J Infect Dis; 1978 May; 137(5):583-6. PubMed ID: 207786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
